Stocks · US
MRNA
XNAS
Moderna, Inc. Common Stock
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E—
P/B12.00x
P/S36.41x
EPS$-7.89
ROE-46.61%
ROA-28.75%
Dividend yield0.00%
Debt/Equity0.09
Free cash flow$-1.2B
Returns and 52-week range
1W-7.86%
1M+28.79%
3M+154.01%
6M+274.10%
1Y+557.99%
YTD+507.45%
52W high$212.22
52W low$22.28
From 52W high-11.67%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| 엘리밴스 헬스 | $85.6B | 17.24 | 1.91 | -1.82% |
| 리제네론 파머슈티컬스 | $74.8B | 17.28 | 2.36 | -10.75% |
| 매케손 | $106.7B | 23.24 | — | +1.51% |
| The Cigna Group | $71.7B | 11.17 | 1.68 | -2.88% |
| 스트라이커 | $109.4B | 29.34 | 4.56 | -8.22% |
| 보스턴 사이언티픽 | $61.4B | 16.72 | 2.46 | -11.74% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.